UNSPSC 51191519: Pamabrom

This classification denotes a diuretic with the molecular formula C7H7BrN4O2.C4H11NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UA8U0KJM72, chemically known as 8-bromo-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione compound with 2-amino-2-methyl-1-propanol (1:1) but generally known as pamabrom, which bears US NIH Compound Identifier 11806. European Medicines Agency schedules Pamabrom in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14745MIG.

As of Q4 2014, PAMABROM remains the US FDA Preferred Term for this commodity. Pamabrom bears US NLM identifiers UMLS ID C0135166 and NCI Concept Code C81076. SMILES: BRC1[NH]C2C(N(C(=O)N(C2=O)C)C)N1.OCC(N)(C)C.

UNSPSC 51191519 Pamabrom, a Commodity code, encompasses chemical supply products used in municipal water treatment and healthcare settings, though recent state and local solicitations under this code show minimal alignment with pamabrom specifically. State and local governments procuring under this category acquire chemicals for water pollution control facilities and generic pharmaceuticals and over-the-counter products for distribution across government health and wellness programs. The issuing bodies include municipal water utilities, state cooperative purchasing alliances, and multi-state collaborative procurement vehicles that aggregate demand across participating jurisdictions and facilities. Insurance requirements vary by solicitation type; water treatment chemical suppliers typically carry General Liability of $1,000,000 to $2,000,000 and Workers' Compensation at statutory limits, while pharmaceutical and OTC product suppliers must maintain commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000.

Recent activity under the code appears concentrated in two distinct procurement streams. The City of Meriden, Connecticut posted an IFB (solicitation B027-15) on July 8, 2026 for sodium bisulfite chemical supply to its Water Pollution Control Facility, with bids due July 29, 2026 and pricing evaluated on a unit-cost basis for estimated quantities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) posted January 20, 2026 with a March 26, 2026 response deadline to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities including Oregon; vendors must comply with current Good Manufacturing Practices and the Drug Supply Chain Security Act, maintain relationships with at least two of three authorized wholesalers, and are subject to a 3 percent administrative fee. The code shows activity in Connecticut and Minnesota; the underlying commodities purchased—chemical treatment products and pharmaceutical supplies—diverge significantly from the nominal code designation.